These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 18704360)
1. [Prevalence of lymph node metastases in non-muscle-invasive bladder cancer. Delay of radical cystectomy and upstaging in the cystectomy specimen as risk factors]. Wiesner C; Thomas C; Salzer A; Gillitzer R; Hampel C; Thüroff JW Urologe A; 2008 Sep; 47(9):1162-6. PubMed ID: 18704360 [TBL] [Abstract][Full Text] [Related]
2. Lymph node metastases in non-muscle invasive bladder cancer are correlated with the number of transurethral resections and tumour upstaging at radical cystectomy. Wiesner C; Pfitzenmaier J; Faldum A; Gillitzer R; Melchior SW; Thüroff JW BJU Int; 2005 Feb; 95(3):301-5. PubMed ID: 15679782 [TBL] [Abstract][Full Text] [Related]
3. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only. Steven K; Poulsen AL J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113 [TBL] [Abstract][Full Text] [Related]
4. The Impact of Lymphovascular Invasion on Risk of Upstaging and Lymph Node Metastasis at the Time of Radical Cystectomy. Werntz RP; Smith ZL; Packiam VT; Smith N; Steinberg GD Eur Urol Focus; 2020 Mar; 6(2):292-297. PubMed ID: 30297221 [TBL] [Abstract][Full Text] [Related]
5. [Radical cystectomy in the treatment of bladder cancer always in due time?]. May M; Braun KP; Richter W; Helke C; Vogler H; Hoschke B; Siegsmund M Urologe A; 2007 Aug; 46(8):913-9. PubMed ID: 17676301 [TBL] [Abstract][Full Text] [Related]
6. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density. Stein JP; Cai J; Groshen S; Skinner DG J Urol; 2003 Jul; 170(1):35-41. PubMed ID: 12796639 [TBL] [Abstract][Full Text] [Related]
7. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118 [TBL] [Abstract][Full Text] [Related]
8. Survival rates after radical cystectomy according to tumor stage of bladder carcinoma at first presentation. May M; Helke C; Nitzke T; Vogler H; Hoschke B Urol Int; 2004; 72(2):103-11. PubMed ID: 14963349 [TBL] [Abstract][Full Text] [Related]
9. Effect of delayed radical cystectomy for invasive bladder tumors on lymph node positivity, cancer-specific survival and total survival. Türk H; Ün S; Cinkaya A; Kodaz H; Parvizi M; Zorlu F Tumori; 2018 Dec; 104(6):434-437. PubMed ID: 28665471 [TBL] [Abstract][Full Text] [Related]
10. Early vs delayed radical cystectomy for 'high-risk' carcinoma not invading bladder muscle: delay of cystectomy reduces cancer-specific survival. Jäger W; Thomas C; Haag S; Hampel C; Salzer A; Thüroff JW; Wiesner C BJU Int; 2011 Oct; 108(8 Pt 2):E284-8. PubMed ID: 21244611 [TBL] [Abstract][Full Text] [Related]
11. Significance of the time period between diagnosis of muscle invasion and radical cystectomy with regard to the prognosis of transitional cell carcinoma of the urothelium in the bladder. May M; Nitzke T; Helke C; Vogler H; Hoschke B Scand J Urol Nephrol; 2004; 38(3):231-5. PubMed ID: 15204377 [TBL] [Abstract][Full Text] [Related]
12. [Muscle-invasive urothelial carcinoma of the bladder. Detection and topography of micrometastases in lymph nodes]. Autenrieth M; Nawroth R; Semmlack S; Gschwend JE; Retz M Urologe A; 2008 Sep; 47(9):1157-61. PubMed ID: 18696039 [TBL] [Abstract][Full Text] [Related]
13. The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy. Wright JL; Lin DW; Porter MP Cancer; 2008 Jun; 112(11):2401-8. PubMed ID: 18383515 [TBL] [Abstract][Full Text] [Related]
14. The role of lymphadenectomy in high-grade invasive bladder cancer. Stein JP; Skinner DG Urol Clin North Am; 2005 May; 32(2):187-97. PubMed ID: 15862616 [TBL] [Abstract][Full Text] [Related]
15. Predictors of adequate lymph node dissection in patients with non-muscle invasive bladder cancer undergoing radical cystectomy and effect on survival. Lenis AT; Lec PM; Michel J; Brisbane W; Golla V; Sharma V; Gollapudi K; Blumberg J; Chamie K Urol Oncol; 2020 Oct; 38(10):796.e7-796.e14. PubMed ID: 32446641 [TBL] [Abstract][Full Text] [Related]
16. Local recurrence after radical cystectomy for invasive bladder cancer: an analysis of predictive factors. Honma I; Masumori N; Sato E; Takayanagi A; Takahashi A; Itoh N; Tamagawa M; Sato MA; Tsukamoto T Urology; 2004 Oct; 64(4):744-8. PubMed ID: 15491713 [TBL] [Abstract][Full Text] [Related]
17. Visceral obesity predicts adverse pathological features in urothelial bladder cancer patients undergoing radical cystectomy: a retrospective cohort study. Cantiello F; Cicione A; Autorino R; Salonia A; Briganti A; Ferro M; De Domenico R; Perdonà S; Damiano R World J Urol; 2014 Apr; 32(2):559-64. PubMed ID: 23942944 [TBL] [Abstract][Full Text] [Related]
18. Ki-67 is an independent predictor of bladder cancer outcome in patients treated with radical cystectomy for organ-confined disease. Margulis V; Shariat SF; Ashfaq R; Sagalowsky AI; Lotan Y Clin Cancer Res; 2006 Dec; 12(24):7369-73. PubMed ID: 17189409 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of risk of muscle invasion, perivesical and/or lymph node affectation by diffusion-weighted magnetic nuclear resonance in the patient who is a candidate for radical cystectomy. Lista F; Andrés G; Cáceres F; Ramón de Fata F; Rodríguez-Barbero JM; Angulo JC Actas Urol Esp; 2013; 37(7):419-24. PubMed ID: 23773823 [TBL] [Abstract][Full Text] [Related]
20. Concordance of PD-L1 expression in matched urothelial bladder cancer specimens. de Jong JJ; Stoop H; Nieboer D; Boormans JL; van Leenders GJLH Histopathology; 2018 Dec; 73(6):983-989. PubMed ID: 30003574 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]